Precision BioSciences Inc.

1.78-0.1100-5.82%Vol 606.03K1Y Perf -80.11%
May 18th, 2022 16:00 DELAYED
BID1.75 ASK1.99
Open1.82 Previous Close1.89
Pre-Market- After-Market1.78
 - -  - -%
Target Price
17.67 
Analyst Rating
Strong Buy 1.00
Potential %
892.70 
Finscreener Ranking
★★★★★     63.31
Insiders Trans % 3/6/12 mo.
-/-/-67 
Value Ranking
★★★+     53.26
Insiders Value % 3/6/12 mo.
52/52/-87 
Growth Ranking
★★★★     58.01
Insiders Shares Cnt. % 3/6/12 mo.
36/36/-63 
Income Ranking
 —    -
Price Range Ratio 52W %
2.25 
Earnings Rating
Sell
Market Cap110.67M 
Earnings Date
9th May 2022
Alpha-0.03 Standard Deviation0.39
Beta1.80 

Today's Price Range

1.761.95

52W Range

1.4914.38

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
14.55%
1 Month
-20.59%
3 Months
-57.05%
6 Months
-79.30%
1 Year
-80.11%
3 Years
-84.83%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
DTIL1.78-0.1100-5.82
AAPL140.82-8.4200-5.64
GOOG2 248.02-86.0100-3.69
MSFT254.08-12.1200-4.55
XOM90.65-1.4600-1.59
WFC42.11-1.6000-3.66
JNJ175.50-3.3200-1.86
FB192.24-10.3800-5.12
GE75.20-1.2000-1.57
JPM120.09-2.0900-1.71
Financial StrengthValueIndustryS&P 500US Markets
4.00
4.50
0.07
0.10
-230.80
Leverage Ratio 2.30
ProfitabilityValueIndustryS&P 500US Markets
-
-26.40
-17.50
-393.30
-12.52
RevenueValueIndustryS&P 500US Markets
99.18M
1.60
86.81
-
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.58-0.4620.69
Q04 2021-0.48-0.3820.83
Q03 2021-0.60-0.1968.33
Q02 2021-0.380.36194.74
Q01 2021-0.49-0.3332.65
Q04 2020-0.50-0.4412.00
Q03 2020-0.68-0.5026.47
Q02 2020-0.60-0.63-5.00
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.4320.37Positive
9/2022 QR-0.4416.98Positive
12/2022 FY-1.739.42Positive
12/2023 FY-1.4827.09Positive
Next Report Date-
Estimated EPS Next Report-0.58
Estimates Count5
EPS Growth Next 5 Years %-
Volume Overview
Volume606.03K
Shares Outstanding62.18K
Shares Float58.02M
Trades Count4.79K
Dollar Volume1.10M
Avg. Volume735.44K
Avg. Weekly Volume802.71K
Avg. Monthly Volume679.29K
Avg. Quarterly Volume724.32K

Precision BioSciences Inc. (NASDAQ: DTIL) stock closed at 1.89 per share at the end of the most recent trading day (a 6.78% change compared to the prior day closing price) with a volume of 570.30K shares and market capitalization of 110.67M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 223 people. Precision BioSciences Inc. CEO is Matthew Kane.

The one-year performance of Precision BioSciences Inc. stock is -80.11%, while year-to-date (YTD) performance is -74.46%. DTIL stock has a five-year performance of %. Its 52-week range is between 1.49 and 14.38, which gives DTIL stock a 52-week price range ratio of 2.25%

Precision BioSciences Inc. currently has a PE ratio of -2.90, a price-to-book (PB) ratio of 1.42, a price-to-sale (PS) ratio of 1.11, a price to cashflow ratio of 521.80, a PEG ratio of 2.32, a ROA of -17.42%, a ROC of -33.93% and a ROE of -46.18%. The company’s profit margin is -12.52%, its EBITDA margin is -17.50%, and its revenue ttm is $99.18 Million , which makes it $1.60 revenue per share.

Of the last four earnings reports from Precision BioSciences Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.58 for the next earnings report. Precision BioSciences Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Precision BioSciences Inc. is Strong Buy (1), with a target price of $17.67, which is +892.70% compared to the current price. The earnings rating for Precision BioSciences Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Precision BioSciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Precision BioSciences Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 11.94, ATR14 : 0.22, CCI20 : -42.74, Chaikin Money Flow : -0.31, MACD : -0.31, Money Flow Index : 45.11, ROC : -5.03, RSI : 40.64, STOCH (14,3) : 54.42, STOCH RSI : 1.00, UO : 39.41, Williams %R : -45.58), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Precision BioSciences Inc. in the last 12-months were: Alan List (Option Excercise at a value of $0), Alan List (Sold 7 775 shares of value $16 328 ), David Thomson (Option Excercise at a value of $76 700), David Thomson (Sold 65 000 shares of value $695 450 ), John Alexander Kelly (Buy at a value of $51 365)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
4 (80.00 %)
4 (80.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
1 (20.00 %)
1 (20.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.40
Strong Buy
1.40

Precision BioSciences Inc.

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The company's segments include Therapeutics and Food.

CEO: Matthew Kane

Telephone: +1 919 314-5512

Address: 302 East Pettigrew Street, Durham 27701, NC, US

Number of employees: 223

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

47%53%

Bearish Bullish

54%46%

TipRanks News for DTIL

Thu, 17 Mar 2022 01:15 GMT Precision BioSciences (DTIL) Receives a Buy from Barclays

- TipRanks. All rights reserved.

News

Stocktwits